Maternal and pediatric nutrition

Efficacy of a galactogogue containing silymarin-phosphatidylserine and galega in mothers of preterm infants: a randomized controlled trial

Abstract

Background/Objectives:

Human milk (HM) is the best possible food for all infants, especially for preterm ones, but lactation and breastfeeding are very difficult for mothers of preterm babies and high rates of breastfeeding difficulties have been reported. Our aim was to investigate the efficacy of a galactogogue containing silymarin-phosphatidylserine and galega in increasing milk production during the first month after delivery in a population of mothers of preterm infants.

Subjects/Methods:

Mothers of infants with gestational age (GA) between 27+0 and 32+6 weeks were enrolled in this prospective, double-blind, randomized trial and were randomly allocated to receive either the galactogogue containing silymarin-phosphatidylserine and galega, 5 g/day (galactogogue group, GG), or a placebo, 5 g of lactose per day (placebo group, PG) from the 3rd to the 28th day after delivery.

Results:

Fifty mothers were included in each group. General characteristics of mothers and pregnancies were similar. Milk production was significantly greater in the GG at the 7th day of life and at the 30th day of life. Daily milk production from the 7th to the 30th day of life was 200 (110–380) ml in the GG vs 115 (60–245) ml in the PG (P<0.0001). The total production of milk during the study period was significantly higher in the GG (6523±5298 ml vs 4136±4093 ml; P<0.02). At the end of the study, 45 mothers of the GG were able to reach the target of milk supply of 200 ml/day compared with 25 mothers of the PG (P<0.01). No adverse reactions were noticed in the study groups.

Conclusions:

Silymarin-phosphatidylserine and galega increased milk production in mothers of preterm infants without any significant side effects.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1
Figure 2

References

  1. 1

    Meier PP, Engstrom JL, Patel AL, Jegier BJ, Bruns NE . Improving the use of human milk during and after the NICU stay. Clin Perinatol 2010; 37: 217–245.

    Article  Google Scholar 

  2. 2

    Jeurink PV, van Bergenhenegouwen J, Jimenez E, Knippels LM, Fernández L, Garssen J et al. Human milk: a source of more life than we imagine. Benef Microbes 2013; 4: 17–30.

    CAS  Article  Google Scholar 

  3. 3

    Riskin A . Changes in immunomodulatory constituents of human milk in response to active infection in the nursing infant. Pediatr Res 2012; 71: 220–225.

    CAS  Article  Google Scholar 

  4. 4

    Levy I, Comarsca J, Davidovits M, Klinger G, Sirota L, Linder N . Urinary tract infection in preterm infants: the protective role of breastfeeding. Pediatr Nephrol 2009; 24: 527–531.

    Article  Google Scholar 

  5. 5

    Schanler RJ, Shulman RJ, Lau C . Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk vs preterm formula. Pediatrics 1999; 103: 1150–1157.

    CAS  Article  Google Scholar 

  6. 6

    Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM . Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007; 27: 428–433.

    CAS  Article  Google Scholar 

  7. 7

    Furman L, Taylor G, Minich N, Hack M . The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med 2003; 157: 66–71.

    Article  Google Scholar 

  8. 8

    Hurst NM . Recognizing and treating delayed or failed lactogenesis II. J Midwifery Womens Health 2007; 52: 588–594.

    Article  Google Scholar 

  9. 9

    Dewey KG, Nommsen-Rivers LA, Heinig MJ, Cohen RJ . Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics 2003; 112: 607–619.

    Article  Google Scholar 

  10. 10

    Nommsen-Rivers LA, Dolan LM, Huang B . Timing of stage II lactogenesis is predicted by antenatal metabolic health in a cohort of primiparas. Breastfeed Med 2012; 7: 43–49.

    Article  Google Scholar 

  11. 11

    Nommsen-Rivers LA, Chantry CJ, Peerson JM, Cohen RJ, Dewey KG . Delayed onset of lactogenesis among first-time mothers is related to maternal obesity and factors associated with ineffective breastfeeding. Am J Clin Nutr 2010; 92: 574–584.

    CAS  Article  Google Scholar 

  12. 12

    Carroll K, Herrmann K . Introducing donor human milk to the NICU: lessons for Australia. Breastfeed Rev 2012; 20: 19–26.

    PubMed  Google Scholar 

  13. 13

    Boyd CA, Quigley MA, Brocklehurst P . Donor breast milk versus infant formula for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2007; 92: F169–F175.

    Article  Google Scholar 

  14. 14

    Arslanoglu S, Ziegler EE, Moro GE . WAPM Working Group on Nutrition. Donor human milk in preterm infant feeding: evidence and recommendations. J Perinat Med 2010; 38: 347–351.

    PubMed  Google Scholar 

  15. 15

    Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C . Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharmaceut Sci 2010; 13: 162–174.

    CAS  Article  Google Scholar 

  16. 16

    Mannion C, Mansell D . Breastfeeding self-efficacy and the use of prescription medication: a pilot study. Obstet Gynecol Int 2012; 2012: 562704.

    Article  Google Scholar 

  17. 17

    Marasco L . Increasing your milk supply with galactogogues. J Hum Lact 2008; 24: 455–456.

    Article  Google Scholar 

  18. 18

    Academy of Breastfeeding Medicine Protocol Committee. ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting the rate of maternal milk secretion (first revision, January 2011). Breastfeed Med 2011; 6: 41–49.

    Article  Google Scholar 

  19. 19

    Nordeng H, Havnen GC . Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004; 13: 371–380.

    Article  Google Scholar 

  20. 20

    Puschner B, Galey FD, Holstege DM, Palazoglu M . Sweet clover poisoning in dairy cattle in California. J Am Vet Med Assoc 1998; 212: 857–859.

    CAS  PubMed  Google Scholar 

  21. 21

    Carotenuto D, Di Pierro F . Studio sulla tollerabilità ed efficacia della silimarina BIO-C® (Piùlatte®) micronizzata come galattagogo. Acta Neonatol Pediatr 2005; 4: 393–340.

    Google Scholar 

  22. 22

    Vojtisek B . Milk Thistel (silybum marianum) in the feed of ketotik cow. Vet Med (Praha) 1991; 36: 321–330.

    CAS  Google Scholar 

  23. 23

    Kren V, Walterova D . Silybin and Silymarin – new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 29–41.

    CAS  Article  Google Scholar 

  24. 24

    Pradhan SC, Girish C . Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006; 124: 491–504.

    CAS  PubMed  Google Scholar 

  25. 25

    Saxena BN, Shrimanker K, Grudzinskas JG . Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception 1977; 16: 605–613.

    CAS  Article  Google Scholar 

  26. 26

    Garavaglia L, Galletti S, Tedesco D . Silymarin and lycopene administration in periparturient dairy cows: effects on milk production and oxidative status. NZ Vet J 2015; 63: 313–318.

    CAS  Article  Google Scholar 

  27. 27

    Capasso R . Effect of Silitidil, a standardized extract of milk thistle, on the serum prolactin levels in female rats. Nat Prod Commun 2014; 9: 943–944.

    CAS  PubMed  Google Scholar 

  28. 28

    Di Pierro F, Callegari A, Carotenuto D, Mollo Tapia M . Clinical efficacy, safety and tolerability of BIO-C (micronized Silymarin) as a galctogogue. Acta Biomed 2008; 79: 205–210.

    CAS  PubMed  Google Scholar 

  29. 29

    Castoldi F, Pivetti V, Moiraghi L, Marangione P, Lista G . Sylimarin/galega administration in term and preterm mothers to sustain breast feeding: an observational study. Minerva Pediatr 2014; 66: 375–378.

    CAS  PubMed  Google Scholar 

  30. 30

    Mortel M, Mehta SD . Systematic review of the efficacy of herbal galactogogues. J Hum Lact 2013; 29: 154.

    Article  Google Scholar 

  31. 31

    Wilinska M, Schleußner E . Galactogogues and breastfeeding. Focus on new natural solutions for hypogalactia. Nutrafoods 2015; 14: 119–125.

    CAS  Article  Google Scholar 

  32. 32

    Ahrabi AF, Schanler RJ . Human milk is the only milk for premies in the NICU! Early Hum Dev 2013; 89: S51–S53.

    Article  Google Scholar 

  33. 33

    Schanker RJ . The use of human milk for premature infants. Pediatr Clin North Am 2001; 48: 207–219.

    Article  Google Scholar 

  34. 34

    Lee J, Kim H-S, Jung YH, Choi KY, Shin SH, Kim E-K et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics 2015; 135: e357.

    Article  Google Scholar 

  35. 35

    Tedesco D, Tava A, Galletti S, Tameni M, Varisco G, Costa et al. Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows. J Dairy Sci 2004; 87: 2239–2247.

    CAS  Article  Google Scholar 

  36. 36

    Siegel AB, Stebbing J . Milk thistle: early seeds of potential. Lancet Oncol 2013; 14: 929–930.

    Article  Google Scholar 

  37. 37

    Mayer KE, Myers RP, Lee SS . Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepatitis 2005; 12: 559–567.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The project was carried out with no specific support. The authors disclose any financial relationships that could be broadly relevant to the work and declare no conflicts of interest. Mothers did not receive any reward for participating in the study. Unique ID issued by UMIN: UMIN000010306.

Author Contributions EZ designed and conducted the study and wrote the final manuscript. AAZ generated the allocation sequence and performed the statistical analysis. AD and LG enrolled participants and assigned them to study groups. ET and TP gave the intervention to the women and collected the data. CR designed the study and revised the final manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to C Romagnoli.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zecca, E., Zuppa, A., D’Antuono, A. et al. Efficacy of a galactogogue containing silymarin-phosphatidylserine and galega in mothers of preterm infants: a randomized controlled trial. Eur J Clin Nutr 70, 1151–1154 (2016). https://doi.org/10.1038/ejcn.2016.86

Download citation

Further reading

Search